05/11/2023
As a proud member of the Obesity Medicine Association, RMWL supports the OMA's position on compounded Semaglutide. With so much controversy surrounding new weight loss medications, it's important to be educated on what's available.
Read the OMA's post to learn more!
The Obesity Medicine Association has released a position statement on compounded medications.
On the topic of compounded medications, OMA President, Dr. Angela Fitch states: "Compounding medications by a pharmacist is sometimes performed to provide a custom formulation of a medication to fit a unique patient need, not otherwise met with a commercially available medicinal product; however, compounding peptides should not be intended for pharmacists to mass produce, store, market, and sell replications of patented medications."
Learn more and read the complete position statement at https://www.sciencedirect.com/science/article/pii/S2667368123000074
